Search Results - Timothy Pluard
- Showing 1 - 7 results of 7
-
1
Molecular Tumor Board-Directed Treatment for Patients with Advanced-Stage Solid Tumors: A Case–Control Real-World Study by Ben Ponvilawan, Dhruv Bansal, Karnav Modi, Beth Gustafson, Lindsey Douglass, Blake Buzard, Marc Roth, Christopher Ward, Timothy Pluard, Janakiraman Subramanian
Published in Current Oncology (2026-05-01)Get full text
Article -
2
Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review by Nadia Harbeck, Adam Brufsky, Chloe Grace Rose, Beata Korytowsky, Connie Chen, Krista Tantakoun, Endri Jazexhi, Do Hoang Vien Nguyen, Meaghan Bartlett, Imtiaz A. Samjoo, Timothy Pluard
Published in Frontiers in Oncology (2025-03-01)Get full text
Article -
3
Real-world effectiveness and safety of CDK4/6i in elderly and BIPOC patients with HR+/HER2- advanced/metastatic breast cancer: an updated systematic literature review by Nadia Harbeck, Adam Brufsky, Chloe Grace Rose, Beata Korytowsky, Connie Chen, Krista Tantakoun, Endri Jazexhi, Do Hoang Vien Nguyen, Meaghan Bartlett, Imtiaz A. Samjoo, Timothy Pluard
Published in Frontiers in Oncology (2025-08-01)Get full text
Article -
4
532 A cross-cohort examination of factors impacting immunotherapy survival in non-small cell lung cancer (NSCLC) by Chris Ward, Nikita Kotlov, Krystle Nomie, Konstantin Danilov, Dhruv Bansal, Ivan Valiev, Vladimir Kushnarev, Ammar Al-Obaidi, Timothy Pluard, Artem Tarasov, Anastasiia Makarova, Anna Butusova, Anna Love, Janakiraman Subramanian, Alexander Bagaev
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
5
Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer by Erika Hamilton, Timothy Pluard, Judy S. Wang, Aki Morikawa, Stephen Johnston, E. Claire Dees, Christos Vaklavas, Anne Armstrong, Pamela Munster, Nisha Unni, Gail S. Wright, Fadi Kayali, Tingting Song, Yuanxin Rong, Kohei Yamaguchi, Dejan Juric
Published in Breast Cancer Research (2025-08-01)Get full text
Article -
6
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique by Emily J. Gallagher, Heather Moore, Mario E. Lacouture, Susan F. Dent, Azeez Farooki, Marcus D. Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura Spring, Brian Berman, Melanie Decker, Gabriel N. Hortobagyi, Benjamin H. Kaffenberger, Bernice Y. Kwong, Timothy Pluard, Ruta Rao, Lee Schwartzberg, Michael S. Broder
Published in npj Breast Cancer (2024-01-01)Get full text
Article -
7
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts by Shunqiang Li, Dong Shen, Jieya Shao, Robert Crowder, Wenbin Liu, Aleix Prat, Xiaping He, Shuying Liu, Jeremy Hoog, Charles Lu, Li Ding, Obi L. Griffith, Christopher Miller, Dave Larson, Robert S. Fulton, Michelle Harrison, Tom Mooney, Joshua F. McMichael, Jingqin Luo, Yu Tao, Rodrigo Goncalves, Christopher Schlosberg, Jeffrey F. Hiken, Laila Saied, Cesar Sanchez, Therese Giuntoli, Caroline Bumb, Crystal Cooper, Robert T. Kitchens, Austin Lin, Chanpheng Phommaly, Sherri R. Davies, Jin Zhang, Megha Shyam Kavuri, Donna McEachern, Yi Yu Dong, Cynthia Ma, Timothy Pluard, Michael Naughton, Ron Bose, Rama Suresh, Reida McDowell, Loren Michel, Rebecca Aft, William Gillanders, Katherine DeSchryver, Richard K. Wilson, Shaomeng Wang, Gordon B. Mills, Ana Gonzalez-Angulo, John R. Edwards, Christopher Maher, Charles M. Perou, Elaine R. Mardis, Matthew J. Ellis
Published in Cell Reports (2013-09-01)Get full text
Article
